Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2017, Article ID 1478606, 17 pages
https://doi.org/10.1155/2017/1478606
Research Article

From Blood to Lesioned Brain: An In Vitro Study on Migration Mechanisms of Human Nasal Olfactory Stem Cells

1Aix Marseille Univ, CNRS, NICN, Marseille, France
2VECT-HORUS SAS, Faculty of Medicine, Marseille, France
3Aix Marseille Univ, CNRS, CRN2M, Marseille, France
4Aix Marseille Univ, IFSTTAR, LBA, Marseille, France
5APHM, CHU Nord, ENT Department, Marseille, France
6APHM, Culture and Cell Therapy Laboratory, CIC BT 1409, Marseille, France

Correspondence should be addressed to François Féron; rf.uma-vinu@noref.siocnarf

Received 5 January 2017; Accepted 19 March 2017; Published 18 June 2017

Academic Editor: Christopher Dearth

Copyright © 2017 Stéphane D. Girard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Kumar, K. Narayanan, R. K. Chaudhary et al., “Current perspective of stem cell therapy in neurodegenerative and metabolic diseases,” Molecular Neurobiology, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. S. U. Kim and J. de Vellis, “Stem cell-based cell therapy in neurological diseases: a review,” Journal of Neuroscience Research, vol. 87, no. 10, pp. 2183–2200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Oki, J. Tatarishvili, J. Wood et al., “Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain,” Stem Cells, vol. 30, no. 6, pp. 1120–1133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Gennai, A. Monsel, Q. Hao et al., “Cell-based therapy for traumatic brain injury,” British Journal of Anaesthesia, vol. 115, no. 2, pp. 203–212, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. S. Boyd, N. P. Rodrigues, K. O. Lui, X. Fu, and Y. Xu, “Concise review: immune recognition of induced pluripotent stem cells,” Stem Cells, vol. 30, no. 5, pp. 797–803, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. A. Somoza and F. J. Rubio, “Cell therapy using induced pluripotent stem cells or somatic stem cells: this is the question,” Current Stem Cell Research & Therapy, vol. 7, no. 3, pp. 191–196, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Y. Li, N. S. Christophersen, V. Hall, D. Soulet, and P. Brundin, “Critical issues of clinical human embryonic stem cell therapy for brain repair,” Trends in Neurosciences, vol. 31, no. 3, pp. 146–153, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Mimeault and S. K. Batra, “Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapies,” Advances in Experimental Medicine and Biology, vol. 741, pp. 171–186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Murrell, F. Féron, A. Wetzig et al., “Multipotent stem cells from adult olfactory mucosa,” Developmental Dynamics, vol. 233, no. 2, pp. 496–515, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Tome, S. L. Lindsay, J. S. Riddell, and S. C. Barnett, “Identification of nonepithelial multipotent cells in the embryonic olfactory mucosa,” Stem Cells, vol. 27, no. 9, pp. 2196–2208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Delorme, E. Nivet, J. Gaillard et al., “The human nose harbors a niche of olfactory ectomesenchymal stem cells displaying neurogenic and osteogenic properties,” Stem Cells and Development, vol. 19, no. 6, pp. 853–866, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. D. Girard, A. Devéze, E. Nivet, B. Gepner, F. S. Roman, and F. Féron, “Isolating nasal olfactory stem cells from rodents or humans,” Journal of Visualized Experiments, no. 54, 2011. View at Publisher · View at Google Scholar
  13. E. Nivet, M. Vignes, S. D. Girard et al., “Engraftment of human nasal olfactory stem cells restores neuroplasticity in mice with hippocampal lesions,” The Journal of Clinical Investigation, vol. 121, no. 7, pp. 2808–2820, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. C. McDonald, A. Mackay-Sim, D. Crane, and W. Murrell, “Could cells from your nose fix your heart? Transplantation of olfactory stem cells in a rat model of cardiac infarction,” Scientific World Journal, vol. 10, pp. 422–433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Xiao, K. M. Klueber, Z. Guo, C. Lu, H. Wang, and F. J. Roisen, “Human adult olfactory neural progenitors promote axotomized rubrospinal tract axonal reinnervation and locomotor recovery,” Neurobiology of Disease, vol. 26, no. 2, pp. 363–374, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Xiao, K. M. Klueber, C. Lu et al., “Human adult olfactory neural progenitors rescue axotomized rodent rubrospinal neurons and promote functional recovery,” Experimental Neurology, vol. 194, no. 1, pp. 12–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Toft, M. Tome, S. L. Lindsay, S. C. Barnett, and J. S. Riddell, “Transplant-mediated repair properties of rat olfactory mucosal OM-I and OM-II sphere-forming cells,” Journal of Neuroscience Research, vol. 90, no. 3, pp. 619–631, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S. R. Pandit, J. M. Sullivan, V. Egger, A. A. Borecki, and S. Oleskevich, “Functional effects of adult human olfactory stem cells on early-onset sensorineural hearing loss,” Stem Cells, vol. 29, no. 4, pp. 670–677, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. P. Xu, X. D. Shan, Y. Y. Liu et al., “Olfactory epithelium neural stem cell implantation restores noise-induced hearing loss in rats,” Neuroscience Letters, vol. 616, pp. 19–25, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Murrell, A. Wetzig, M. Donnellan et al., “Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease,” Stem Cells, vol. 26, no. 8, pp. 2183–2192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Liu, J. Zhou, X. Zhang et al., “Strategies to optimize adult stem cell therapy for tissue regeneration,” International Journal of Molecular Sciences, vol. 17, no. 6, article 982, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. H. Li, L. Feng, G. X. Zhang, and C. G. Ma, “Intranasal delivery of stem cells as therapy for central nervous system disease,” Experimental and Molecular Pathology, vol. 98, no. 2, pp. 145–151, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. “Mesenchymal stem cells for brain disorders,” [https://clinicaltrials.gov/ct2/results?term=mesenchymal+stem+cells+for+brain+disorders&Search=Search].
  24. E. Chavakis, C. Urbich, and S. Dimmeler, “Homing and engraftment of progenitor cells: a prerequisite for cell therapy,” Journal of Molecular and Cellular Cardiology, vol. 45, no. 4, pp. 514–522, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Belmadani, P. B. Tran, D. Ren, and R. J. Miller, “Chemokines regulate the migration of neural progenitors to sites of neuroinflammation,” The Journal of Neuroscience, vol. 26, no. 12, pp. 3182–3191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Q. Xu, S. Wang, X. Jiang et al., “Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitro,” Clinical and Experimental Pharmacology & Physiology, vol. 34, no. 7, pp. 624–631, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Sun, J. Lee, and H. A. Fine, “Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury,” The Journal of Clinical Investigation, vol. 113, no. 9, pp. 1364–1374, 2004. View at Publisher · View at Google Scholar
  28. D. Widera, W. Holtkamp, F. Entschladen et al., “MCP-1 induces migration of adult neural stem cells,” European Journal of Cell Biology, vol. 83, no. 8, pp. 381–387, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. S. N. Magge, S. Z. Malik, N. C. Royo et al., “Role of monocyte chemoattractant protein-1 (MCP-1/CCL2) in migration of neural progenitor cells toward glial tumors,” Journal of Neuroscience Research, vol. 87, no. 7, pp. 1547–1555, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Ansboro, U. Greiser, F. Barry, and M. Murphy, “Strategies for improved targeting of therapeutic cells: implications for tissue repair,” European Cells & Materials, vol. 23, pp. 310–318, 2012, discussion 318-319. View at Publisher · View at Google Scholar
  31. A. Ould-Yahoui, O. Sbai, K. Baranger et al., “Role of matrix metalloproteinases in migration and neurotrophic properties of nasal olfactory stem and ensheathing cells,” Cell Transplantation, vol. 22, no. 6, pp. 993–1010, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Molino, F. Jabes, E. Lacassagne, N. Gaudin, and M. Khrestchatisky, “Setting-up an in vitro model of rat blood-brain barrier (BBB): a focus on BBB impermeability and receptor-mediated transport,” Journal of Visualized Experiments, no. 88, Article ID e51278, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Beillard, N. Pallisgaard, V. H. van der Velden et al., “Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program,” Leukemia, vol. 17, no. 12, pp. 2474–2486, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Wiggins and J. Rappoport, “An agarose spot assay for chemotactic invasion,” BioTechniques, vol. 48, no. 2, pp. 121–124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Vinader, Y. Al-Saraireh, H. L. Wiggins et al., “An agarose spot chemotaxis assay for chemokine receptor antagonists,” Journal of Pharmacological and Toxicological Methods, vol. 64, no. 3, pp. 213–216, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Steingen, F. Brenig, L. Baumgartner, J. Schmidt, A. Schmidt, and W. Bloch, “Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells,” Journal of Molecular and Cellular Cardiology, vol. 44, no. 6, pp. 1072–1084, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. V. F. Segers, I. Van Riet, L. J. Andries et al., “Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 290, no. 4, pp. H1370–H1377, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Ruster, S. Göttig, R. J. Ludwig et al., “Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells,” Blood, vol. 108, no. 12, pp. 3938–3944, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Liu, M. A. Eckert, H. Riazifar, D. K. Kang, D. Agalliu, and W. Zhao, “From blood to the brain: can systemically transplanted mesenchymal stem cells cross the blood-brain barrier?” Stem Cells International, vol. 2013, Article ID 435093, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. W. A. Muller, “Mechanisms of leukocyte transendothelial migration,” Annual Review of Pathology, vol. 6, pp. 323–344, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Ge, M. Jiang, D. Duan et al., “Secretome of olfactory mucosa mesenchymal stem cell, a multiple potential stem cell,” Stem Cells International, vol. 2016, Article ID 1243659, 16 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. D. H. Park, D. J. Eve, J. Musso 3rd et al., “Inflammation and stem cell migration to the injured brain in higher organisms,” Stem Cells and Development, vol. 18, no. 5, pp. 693–702, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. R. M. Ransohoff and M. A. Brown, “Innate immunity in the central nervous system,” The Journal of Clinical Investigation, vol. 122, no. 4, pp. 1164–1171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. J. van Beek, K. Elward, and P. Gasque, “Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection,” Annals of the new York Academy of Sciences, vol. 992, pp. 56–71, 2003. View at Google Scholar
  45. J. Mocco, W. J. Mack, A. F. Ducruet et al., “Complement component C3 mediates inflammatory injury following focal cerebral ischemia,” Circulation Research, vol. 99, no. 2, pp. 209–217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. I. U. Schraufstatter, R. G. Discipio, M. Zhao, and S. K. Khaldoyanidi, “C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation,” Journal of Immunology, vol. 182, no. 6, pp. 3827–3836, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Chabas, “Osteopontin, a multi-faceted molecule,” Medical Science (Paris), vol. 21, no. 10, pp. 832–838, 2005. View at Publisher · View at Google Scholar
  48. X. Wang, C. Louden, T. L. Yue et al., “Delayed expression of osteopontin after focal stroke in the rat,” The Journal of Neuroscience, vol. 18, no. 6, pp. 2075–2083, 1998. View at Google Scholar
  49. J. A. Ellison, J. J. Velier, P. Spera et al., “Osteopontin and its integrin receptor alpha(v)beta3 are upregulated during formation of the glial scar after focal stroke,” Stroke, vol. 29, no. 8, pp. 1698–1706, 1998, discussion 1707. View at Publisher · View at Google Scholar
  50. L. F. Raheja, D. C. Genetos, and C. E. Yellowley, “Hypoxic osteocytes recruit human MSCs through an OPN/CD44-mediated pathway,” Biochemical and Biophysical Research Communications, vol. 366, no. 4, pp. 1061–1066, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Zou, G. Song, Q. Luo, L. Yuan, and L. Yang, “Mesenchymal stem cells require integrin beta1 for directed migration induced by osteopontin in vitro,” In Vitro Cellular & Developmental Biology. Animal, vol. 47, no. 3, pp. 241–250, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. P. Yan, B. T. Lang, R. Vemuganti, and R. J. Dempsey, “Persistent migration of neuroblasts from the subventricular zone to the injured striatum mediated by osteopontin following intracerebral hemorrhage,” Journal of Neurochemistry, vol. 109, no. 6, pp. 1624–1635, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. P. Yan, B. T. Lang, R. Vemuganti, and R. J. Dempsey, “Osteopontin is a mediator of the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia,” Neurochemistry International, vol. 55, no. 8, pp. 826–832, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Croitoru-Lamoury, F. M. Lamoury, J. J. Zaunders, L. A. Veas, and B. J. Brew, “Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone,” Journal of Interferon & Cytokine Research, vol. 27, no. 1, pp. 53–64, 2007. View at Publisher · View at Google Scholar
  55. C. Israelsson, H. Bengtsson, A. Lobell et al., “Appearance of Cxcl10-expressing cell clusters is common for traumatic brain injury and neurodegenerative disorders,” The European Journal of Neuroscience, vol. 31, no. 5, pp. 852–863, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Tamura, K. Matsumura, M. Sano et al., “Neural crest-derived stem cells migrate and differentiate into cardiomyocytes after myocardial infarction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 3, pp. 582–589, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. X. S. Liu, Z. G. Zhang, R. L. Zhang et al., “Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after stroke,” Journal of Neuroscience Research, vol. 85, no. 10, pp. 2120–2125, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. P. Yan, K. A. Sailor, B. T. Lang, S. W. Park, R. Vemuganti, and R. J. Dempsey, “Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 6, pp. 1213–1224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. R. M. Dwyer, S. M. Potter-Beirne, K. A. Harrington et al., “Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells,” Clinical Cancer Research, vol. 13, no. 17, pp. 5020–5027, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Belema-Bedada, S. Uchida, A. Martire, S. Kostin, and T. Braun, “Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2,” Cell Stem Cell, vol. 2, no. 6, pp. 566–575, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Wang, Y. Li, J. Chen et al., “Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture,” Experimental Hematology, vol. 30, no. 7, pp. 831–836, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. E. G. Vrotsos and K. Sugaya, “MCP-1-induced migration of NT2 neuroprogenitor cells involving APP signaling,” Cellular and Molecular Neurobiology, vol. 29, no. 3, pp. 373–381, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. R. H. Andres, R. Choi, A. V. Pendharkar et al., “The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain,” Stroke, vol. 42, no. 10, pp. 2923–2931, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. G. Brooke, H. Tong, J. P. Levesque, and K. Atkinson, “Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta,” Stem Cells and Development, vol. 17, no. 5, pp. 929–940, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. A. L. Ponte, E. Marais, N. Gallay et al., “The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities,” Stem Cells, vol. 25, no. 7, pp. 1737–1745, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Wu and R. C. Zhao, “The role of chemokines in mesenchymal stem cell homing to myocardium,” Stem Cell Reviews, vol. 8, no. 1, pp. 243–250, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. V. Sordi, M. L. Malosio, F. Marchesi et al., “Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets,” Blood, vol. 106, no. 2, pp. 419–427, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. P. M. Murphy, M. Baggiolini, I. F. Charo et al., “International union of pharmacology. XXII. Nomenclature for chemokine receptors,” Pharmacological Reviews, vol. 52, no. 1, pp. 145–176, 2000. View at Google Scholar
  69. A. Zlotnik and O. Yoshie, “The chemokine superfamily revisited,” Immunity, vol. 36, no. 5, pp. 705–716, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Dagouassat, N. Suffee, H. Hlawaty et al., “Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells,” International Journal of Cancer, vol. 126, no. 5, pp. 1095–1108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. T. Zhang, R. Somasundaram, K. Berencsi et al., “Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4,” European Journal of Immunology, vol. 36, no. 2, pp. 457–467, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. M. S. Kim, C. L. Magno, C. J. Day, and N. A. Morrison, “Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES,” Journal of Cellular Biochemistry, vol. 97, no. 3, pp. 512–518, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. K. Cai, D. Qi, X. Hou et al., “MCP-1 upregulates amylin expression in murine pancreatic beta cells through ERK/JNK-AP1 and NF-kappaB related signaling pathways independent of CCR2,” PloS One, vol. 6, no. 5, Article ID e19559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. A. D. Schecter, A. B. Berman, L. Yi et al., “MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cells,” Journal of Leukocyte Biology, vol. 75, no. 6, pp. 1079–1085, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. A. D. Schecter, B. J. Rollins, Y. J. Zhang et al., “Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells,” The Journal of Biological Chemistry, vol. 272, no. 45, pp. 28568–28573, 1997. View at Publisher · View at Google Scholar · View at Scopus
  76. N. Xiong, Y. Fu, S. Hu, M. Xia, and J. Yang, “CCR10 and its ligands in regulation of epithelial immunity and diseases,” Protein & Cell, vol. 3, no. 8, pp. 571–580, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. A. M. Miller and N. Stella, “Microglial cell migration stimulated by ATP and C5a involve distinct molecular mechanisms: quantification of migration by a novel near-infrared method,” Glia, vol. 57, no. 8, pp. 875–883, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. E. Van Coillie, J. Van Damme, and G. Opdenakker, “The MCP/eotaxin subfamily of CC chemokines,” Cytokine & Growth Factor Reviews, vol. 10, no. 1, pp. 61–86, 1999. View at Publisher · View at Google Scholar · View at Scopus
  79. W. Luini, S. Sozzani, J. Van Damme, and A. Mantovani, “Species-specificity of monocyte chemotactic protein-1 and -3,” Cytokine, vol. 6, no. 1, pp. 28–31, 1994. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Sodek, B. Ganss, and M. D. McKee, “Osteopontin,” Critical Reviews in Oral Biology and Medicine, vol. 11, no. 3, pp. 279–303, 2000. View at Publisher · View at Google Scholar